Minimalist TAVR to the Max

Transcatheter aortic valve replacement (TAVR) is increasingly being performed under conscious sedation, which is associated with a multi-point benefit (including mortality). 

sedación consciente TAVI

This paper, recently published in JACC Intv., shows that general anesthesia is becoming obsolete, although the magnitude the benefit derived from conscious sedation appears to be lower than in previous studies.

The aim of this study was to examine variation in the use of conscious sedation for transcatheter aortic valve replacement across hospitals and over time. Another aim was to detect signs showing the impact (if any) of this type of anesthesia on outcomes, compared with general anesthesia.

The study included 120,080 patients in the Transcatheter Valve Therapy (TVT) Registry who underwent transfemoral transcatheter aortic valve replacement between 2016 and 2019.

Over the study period, the use of conscious sedation increased from 33% to 64% in the general population. There was a great dispersion among sites, ranging from 0% to 91% of cases.


Read also: Virtual ACC 2020 | Conscious Sedation in TAVR.


Conscious sedation was associated with decreased in-hospital mortality and 30-day mortality, shorter hospitalization time, and more frequent discharge to home (instead of a rehabilitation center, for example), compared with general anesthesia.

However, the magnitude of the benefit derived was lower than in previous studies using a propensity score–based approach to compare populations.

Conclusion

The use of conscious sedation for transcatheter aortic valve replacement continues to increase in order to minimize and simplify our procedures, although there remains wide variation across hospitals and professionals. The multiple derived benefits observed in this study, compared with general anesthesia, were less than in previous studies.

Original Title: Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement. Variation in Practice and Outcomes.

Reference: Neel M. Butala et al. J Am Coll Cardiol Intv 2020;13:1277–87. https://doi.org/10.1016/j.jcin.2020.03.008.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...